Brant A. Inman, MD MS FRCSC
Brant A. Inman, MD MS FRCSC
Chin-Hardie Chair of Urologic Oncology, Western University
Потвърден имейл адрес: uwo.ca
Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology
TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the National Comprehensive Cancer Network 18 (3), 329-354, 2020
PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata: associations with localized stage progression
BA Inman, TJ Sebo, X Frigola, H Dong, EJ Bergstralh, I Frank, Y Fradet, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease
BA Inman, JLS Sauver, DJ Jacobson, ME McGree, A Nehra, MM Lieber, ...
Mayo Clinic Proceedings 84 (2), 108-113, 2009
Bladder cancer
PE Clark, N Agarwal, MC Biagioli, MA Eisenberger, RE Greenberg, ...
Journal of the National Comprehensive Cancer Network 11 (4), 446-475, 2013
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma
X Frigola, BA Inman, CM Lohse, CJ Krco, JC Cheville, RH Thompson, ...
Clinical cancer research 17 (7), 1915-1923, 2011
Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with …
RJ Sylvester, W Oosterlinck, S Holmang, MR Sydes, A Birtle, ...
European urology 69 (2), 231-244, 2016
Urachal carcinoma: clinicopathologic features and long‐term outcomes of an aggressive malignancy
RA Ashley, BA Inman, TJ Sebo, BC Leibovich, ML Blute, ED Kwon, ...
Cancer 107 (4), 712-720, 2006
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy
TJ Roth, Y Sheinin, CM Lohse, SM Kuntz, X Frigola, BA Inman, ...
Cancer research 67 (16), 7893-7900, 2007
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ...
The lancet oncology 22 (1), 107-117, 2021
Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology
PE Spiess, N Agarwal, R Bangs, SA Boorjian, MK Buyyounouski, ...
Journal of the National Comprehensive Cancer Network 15 (10), 1240-1267, 2017
NCCN guidelines insights: bladder cancer, version 5.2018
TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the national comprehensive cancer network 16 (9), 1041-1053, 2018
The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review
RJM Lammers, JA Witjes, BA Inman, I Leibovitch, M Laufer, O Nativ, ...
European urology 60 (1), 81-93, 2011
Urachal anomalies: a longitudinal study of urachal remnants in children and adults
RA Ashley, BA Inman, JC Routh, AL Rohlinger, DA Husmann, SA Kramer
The Journal of urology 178 (4S), 1615-1618, 2007
Atezolizumab: A PD-L1–blocking antibody for bladder cancer
BA Inman, TA Longo, S Ramalingam, MR Harrison
Clinical Cancer Research 23 (8), 1886-1890, 2017
Penile cancer
PE Clark, PE Spiess, N Agarwal, MC Biagioli, MA Eisenberger, ...
Journal of the National Comprehensive Cancer Network 11 (5), 594-615, 2013
Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review
JC Routh, BA Inman, Y Reinberg
Pediatrics 125 (5), 1010-1019, 2010
Intravesical rAd–IFNα/Syn3 for patients with high-grade, Bacillus Calmette-Guerin–refractory or relapsed non–muscle-invasive bladder cancer: a phase II randomized study
ND Shore, SA Boorjian, DJ Canter, K Ogan, LI Karsh, TM Downs, ...
Journal of Clinical Oncology 35 (30), 3410, 2017
Curative treatment for muscle invasive bladder cancer in elderly patients: a systematic review
V Fonteyne, P Ost, J Bellmunt, JP Droz, P Mongiat-Artus, B Inman, ...
European urology 73 (1), 40-50, 2018
The role of partial nephrectomy for the management of sporadic renal angiomyolipoma
SA Boorjian, I Frank, B Inman, CM Lohse, JC Cheville, BC Leibovich, ...
Urology 70 (6), 1064-1068, 2007
Soluble B7-H1: differences in production between dendritic cells and T cells
X Frigola, BA Inman, CJ Krco, X Liu, SM Harrington, PA Bulur, AB Dietz, ...
Immunology letters 142 (1-2), 78-82, 2012
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20